全球体学化验服务市场规模、份额、趋势和成长分析报告（2026-2034年）

预计体学化验服务市场将从 2025 年的 1,035.2 亿美元成长到 2034 年的 3,417.4 亿美元，2026 年至 2034 年的复合年增长率为 14.19%。

由于基因组学、蛋白质组学和代谢体学研究的需求不断增长，全球体学化验服务市场正在扩张。这些服务为个人化医疗、药物研发和疾病诊断等领域的前沿研究提供支援。生命科学研究投入的增加以及慢性病盛行率的上升是推动市场成长的主要因素。研究机构和製药公司越来越多地将体学服务外包给专业实验室。

关键成长要素包括定序技术和生物资讯学工具的技术进步。基因测序成本的降低使得体学研究更容易进行。人们对精准医疗和标靶治疗日益增长的兴趣也推动了对全面体学分析的需求。此外，政府资助和合作研究计划正在加速全球体学研究的扩展。

展望未来，由于多组体学方法的不断创新，市场预计将显着增长。人工智慧和巨量资料分析的融合有望提高研究效率并加深洞见。新兴经济体生物技术和製药业的扩张将创造新的服务机会。随着个人化医疗日益重要，体学实验室服务将在塑造医学研究和治疗方法发展的未来中发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体学化验服务市场：依服务类型划分

• 市场分析、洞察与预测
• 基因组学
• 蛋白质体学
• 转录组分析
• 代谢体学
• 表观遗传学

第五章 全球体学化验服务市场：依最终用途划分

• 市场分析、洞察与预测
• 硬体设备（设备、套件、晶片）
• 检测/实验室（服务）
• 分析/解释（个人化和解释）

第六章 全球体学化验服务市场：依产品划分

• 市场分析、洞察与预测
• 一度
• 转发
• 连续的

第七章 全球体学化验服务市场：依服务频率划分

• 市场分析、洞察与预测
• 医院
• 研究机构
• 诊断检查室

第八章 全球体学化验服务市场：依业务类型划分

• 市场分析、洞察与预测
• 癌症
• 药品（处方笺药、非处方药）
• 生殖
• 其他基因检测
• 法医学
• 人口普查
• 护肤
• 营养
• 维生素和补充剂
• 系谱
• 其他类别

第九章 全球体学化验服务市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies Inc
  • Beijing Genomics Institute（BGI）
  • Q2 Solutions
  • Spectrus
  • Flomics Biotech
  • PhenoSwitch Bioscience
  • Qiagen
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc

The Omics Lab Services Market size is expected to reach USD 341.74 Billion in 2034 from USD 103.52 Billion (2025) growing at a CAGR of 14.19% during 2026-2034.

The Global Omics Lab Services Market is expanding due to the increasing demand for genomics, proteomics, and metabolomics research. These services support advanced studies in personalized medicine, drug discovery, and disease diagnostics. Rising investments in life sciences research and the growing prevalence of chronic diseases are key factors driving market growth. Research institutions and pharmaceutical companies are increasingly outsourcing omics services to specialized laboratories.

Major growth drivers include technological advancements in sequencing technologies and bioinformatics tools. The decreasing cost of genomic sequencing has made omics research more accessible. Growing interest in precision medicine and targeted therapies is also fueling demand for comprehensive omics analysis. Additionally, government funding and collaborative research projects are encouraging the expansion of omics-based studies worldwide.

Looking forward, the market is expected to witness significant growth due to continuous innovation in multi-omics approaches. Integration of artificial intelligence and big data analytics will improve research efficiency and insights. Expansion of biotechnology and pharmaceutical industries in emerging economies will create new service opportunities. As personalized healthcare becomes more prominent, omics lab services will play a crucial role in shaping the future of medical research and treatment development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Genomics
• Proteomics
• Transcriptomic
• Metabolomics
• Epigenetics

By End-Use

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Product

• One-off
• Repeat
• Continuous

By Frequency of Service

• Hospitals
• Research Institutes
• Diagnostic Labs

By Business

• Cancer
• Pharmaco (Prescription, Non-Prescription)
• Reproductive
• Other Genetic Tests
• Forensics
• Population Studies
• Skincare
• Nutrition
• Vitamins and Supplements
• Genealogy
• Other Categories

COMPANIES PROFILED

• Agilent Technologies Inc, Beijing Genomics Institute BGI, Q2 Solutions, Spectrus, Flomics Biotech, PhenoSwitch Bioscience, Qiagen, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OMICS LAB SERVICES MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Transcriptomic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OMICS LAB SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OMICS LAB SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. One-off Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Repeat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Continuous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OMICS LAB SERVICES MARKET: BY FREQUENCY OF SERVICE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Frequency Of Service
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL OMICS LAB SERVICES MARKET: BY BUSINESS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Business
• 8.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaco (Prescription, Non-Prescription) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Reproductive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Population Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Skincare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.9. Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.10. Vitamins and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.11. Genealogy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.12. Other Categories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL OMICS LAB SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Services
  • 9.2.2 By End-use
  • 9.2.3 By Product
  • 9.2.4 By Frequency Of Service
  • 9.2.5 By Business
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Services
  • 9.3.2 By End-use
  • 9.3.3 By Product
  • 9.3.4 By Frequency Of Service
  • 9.3.5 By Business
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Services
  • 9.4.2 By End-use
  • 9.4.3 By Product
  • 9.4.4 By Frequency Of Service
  • 9.4.5 By Business
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Services
  • 9.5.2 By End-use
  • 9.5.3 By Product
  • 9.5.4 By Frequency Of Service
  • 9.5.5 By Business
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Services
  • 9.6.2 By End-use
  • 9.6.3 By Product
  • 9.6.4 By Frequency Of Service
  • 9.6.5 By Business
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL OMICS LAB SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Beijing Genomics Institute (BGI)
  • 11.2.3 Q2 Solutions
  • 11.2.4 Spectrus
  • 11.2.5 Flomics Biotech
  • 11.2.6 PhenoSwitch Bioscience
  • 11.2.7 Qiagen
  • 11.2.8 Quest Diagnostics Incorporated
  • 11.2.9 Thermo Fisher Scientific Inc